FSHR and ovarian cancer: Reverse transcriptase-polymerase chain reaction (RT-PCR) analyses have shown, unequivocally, that FSHR is transcribed in extra gonadal tissues as well, particularly in the human female reproductive tract and the placenta [8], in benign prostatic hyperplasia [9,10,11], prostate cancer [9,10,11], and ovarian cancer [12,13,14].